Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Microbiol.

Sec. Systems Microbiology

Volume 16 - 2025 | doi: 10.3389/fmicb.2025.1633360

Comparative Evaluation of Sequencing Platforms: Pacific Biosciences, Oxford Nanopore Technologies, and Illumina for 16S rRNA-Based Soil Microbiome Profiling

Provisionally accepted
Vladimir  VeselovskyVladimir Veselovsky1Mikhail  V RomanovMikhail V Romanov1Polina  ZorukPolina Zoruk1Andrey  LarinAndrey Larin1Vladislav  V. BabenkoVladislav V. Babenko1Maxim  Denisovich MorozovMaxim Denisovich Morozov1Aleksandra  StrokachAleksandra Strokach1Natalia  ZakharevichNatalia Zakharevich1Sadokatkhon  I KhamidovaSadokatkhon I Khamidova1Albina  A DanilovaAlbina A Danilova2Aleksey  VatlinAleksey Vatlin3Vsevolod  PavshintsevVsevolod Pavshintsev3Feng  ChenguangFeng Chenguang3Denis  A TsybizovDenis A Tsybizov3Nikita  A MitkinNikita A Mitkin4Olesya  O GalanovaOlesya O Galanova5Alexander  M ZakharenkoAlexander M Zakharenko2Kirill  GolokhvastKirill Golokhvast2Ksenia  M KliminaKsenia M Klimina1*
  • 1Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia
  • 2Siberian Federal Research Center of Agrobiotechnology RAS, Krasnoobsk, Russia
  • 3Institute of Ecology, Рeoples’ Friendship University of Russia (RUDN University), Moscow, Russia
  • 4Collagel LLC, Moscow, Russia
  • 5Moscow Center for Advanced Studies, Moscow, Russia

The final, formatted version of the article will be published soon.

Soil microbiome profiling is critical for understanding microbial diversity and its roles in ecosystem functioning and agricultural productivity. Recent advancements in highthroughput sequencing, particularly Pacific Biosciences (PacBio) and Oxford Nanopore Technologies (ONT), offer long-read sequencing capabilities that enhance microbial community analysis. In this study, we performed a comparative evaluation of 16S rRNA gene sequencing using Illumina (V4 and V3-V4 regions), PacBio (full-length and trimmed V3-V4/V4 regions), and ONT (full-length) to assess bacterial diversity in soil microbiomes. We analyzed three distinct soil types and applied standardized bioinformatics pipelines tailored to each platform. To ensure comparability, sequencing depth was normalized across platforms (10,000, 20,000, 25,000, and 35,000 reads per sample). Our results demonstrated that ONT and PacBio provided comparable bacterial diversity assessments, with PacBio showing slightly higher efficiency in detecting low-abundance taxa. Despite differences in sequencing accuracy, ONT produced results that closely matched those of PacBio, suggesting that ONT's inherent sequencing errors do not significantly affect the interpretation of well-represented taxa. Our study demonstrated that, regardless of the sequencing technology used and the choice of the target region (full-length 16S rRNA gene or its regions), microbial community analysis ensures clear clustering of samples based on soil type. The only exception is the V4 region, where no soil-type clustering is observed (P = 0.79). These results provide a comprehensive evaluation of sequencing platform performance.

Keywords: Environmental sample, Full-length 16S rRNA sequencing, V3-V4 and V4 regions, PacBio, Oxford nanopore, Illumina, soil microbiome, Sequencing platform comparison

Received: 22 May 2025; Accepted: 24 Jul 2025.

Copyright: © 2025 Veselovsky, Romanov, Zoruk, Larin, Babenko, Morozov, Strokach, Zakharevich, Khamidova, Danilova, Vatlin, Pavshintsev, Chenguang, Tsybizov, Mitkin, Galanova, Zakharenko, Golokhvast and Klimina. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Ksenia M Klimina, Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.